• Price Band fixed at ₹ 42 per equity share of face value ₹1 each to ₹ 45 per equity share of the face value of ₹1 each (“Equity Shares”) of Hexagon Nutrition Limited (the “Company”)
  • Anchor Investor Bidding Date – Thursday, June 04, 2026
  • Bid /Offer Opening Date – Friday, June 05, 2026, and Bid/ Offer Closing Date – Tuesday, June 09, 2026
  • Bids can be made for a minimum of 333 Equity Shares and in multiples of 333 Equity Shares thereafter
  • RHP Link: https://www.cumulativecapital.group/Admin/UploadedFiles/RHP-Hexagon-Nutrition-Limited-May-25,-2026.pdf

National: Hexagon Nutrition Limited (the “Company”) proposes to open an initial public offering (“Offer”) of its equity shares of face value of ₹1 each (“Equity Shares”) on Friday, June 05, 2026. The Anchor Investor Bidding Date is one Working Day before the Bid/Offer Opening Date, being Thursday, June 04, 2026. The Bid/ Offer Closing Date is Tuesday, June 09, 2026.

The Price Band of the Offer has been fixed from ₹ 42 per Equity Share to ₹ 45 per Equity Share. Bids can be made for a minimum of 333 Equity Shares and multiples of 333 Equity Shares thereafter.

The offer comprises an offer for sale of up to 30,859,704 Equity Shares, aggregating up to ₹1,388.69 million (₹138.87 Crore (calculated at upper end of the price band)) by existing shareholders, Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Aditya Kelkar (“Promoter Selling Shareholder”) and Nutan Subhash Kelkar (“Promoter Group Selling Shareholder”)

Hexagon Nutrition Limited is a focused nutrition company with a differentiated and research-oriented approach, operating across the nutrition value chain through Branded wellness nutrition products/ clinical nutrition products (B2C), premix formulations (B2B2C), and Ready to Use Foods (“RUFs”) and Micronutrient Powder (“MNPs”) (ESG segment). The company is recognized as one of the largest premix players in India, supplying customised vitamin and mineral premixes to leading Indian and multinational FMCG companies. It is also one of the largest licensed suppliers of MNPs under UN programmes, supporting global food fortification and public health initiatives (Source: CARE Report)

Internationally, Hexagon Nutrition’s distribution network extends across non-exclusive 19 regional distributors covering Latin America, Southeast Asia, Africa, and the Middle East. The company also maintain 3 overseas offices located in South Africa, Uzbekistan and Hong Kong that support the overseas business operations. Over the past three Fiscals, their products were exported to over 75 countries. The Company has positioned itself as a holistic nutrition company with global nutritional expertise.

The Offer is being made in terms of Rule 19(2)(b) of the SCRR, read with Regulation 31 of the SEBI ICDR Regulations. The Offer is being made for at least 25% of the post- Offer paid-up Equity Share capital of our Company. The Offer is being made through the Book Building Process in accordance with Regulation 6(1) of the SEBI ICDR Regulations wherein in terms of Regulation 32(1) of the SEBI ICDR Regulations, not more than 50% of the Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (“QIBs” and such portion the “QIB Portion”), provided that our Company may, in consultation with the Book Running Lead Managers, allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis, in accordance with the SEBI ICDR Regulations (the “Anchor Investor Portion”), of which 40% shall be reserved as follows: (i) 33.33% for domestic Mutual Funds; and (ii) 6.67% for Life Insurance Companies and Pension Funds, subject to valid Bids being received from domestic Mutual Funds, Life Insurance Companies and Pension Funds at or above the Anchor Investor Offer Price. In case the aggregate demand from Life Insurance Companies and Pension Funds is less than 6.67%, the remaining Equity Shares will be added to the portion allocated to domestic Mutual Funds, in accordance with the SEBI ICDR Regulations. In the event of under-subscription or non-allocation in the Anchor Investor Portion, the balance Equity Shares shall be added to the remaining QIB Portion (“Net QIB Portion”).

Further, 5% of the Net QIB Portion shall be available for allocation on a proportionate basis only to Mutual Funds, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIBs, including Mutual Funds, subject to valid Bids being received at or above the Offer Price. However, if the aggregate demand from the Mutual Funds is less than 5% of the Net QIB Portion, the balance Equity Shares available for allocation will be added to the remaining QIB Portion for proportionate allocation to QIBs. Further, not less than 15% of the Offer shall be available for allocation on a proportionate basis to Non-Institutional Bidders in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Offer Price, out of which (a) one-third of such portion shall be reserved for Bidders with application size of more than ₹ 0.20 million and up to ₹1.00 million; and (b) two-thirds of such portion shall be reserved for Bidders with application size of more than ₹1.00 million provided that the unsubscribed portion in either of such sub-categories may be allocated to Bidders in the other sub-category of Non-Institutional Bidders; and not less than 35% of the Offer shall be available for allocation to Retail Individual Bidders in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Offer Price.

All Bidders (except Anchor Investors) are mandatorily required to utilize the Application Supported by Blocked Amount (“ASBA”) process by providing details of their respective ASBA accounts and UPI ID in case of UPI Bidders using the UPI Mechanism, as applicable, pursuant to which their corresponding Bid Amount will be blocked by the Self Certified Syndicate Banks (“SCSBs”) or by the Sponsor Banks under the UPI Mechanism, as the case may be, to the extent of the respective Bid Amounts. Anchor Investors are not permitted to participate in the Offer through the ASBA process.

The Equity Shares of the Company are proposed to be listed on BSE Limited (BSE) and the National Stock Exchange of India Limited (NSE) (BSE and NSE together, the Stock Exchanges).  For the purposes of the Offer, the Designated Stock Exchange shall be NSE.

Cumulative Capital Private Limited and Catalyst Capital Partners Private Limited are the Book Running Lead Managers (BRLMs) to the issue.

All capitalised terms not defined herein would have the same meaning as attributed to them in the Red Herring Prospectus dated May 25, 2026.